首页> International journal of cardiology> Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis.

Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis.

导出 OA

翻译打印收藏纠错

第一作者： Salim S,Hayek

第一单位： Division of Cardiology, Emory University School of Medicine, Atlanta, GA, United States.

作者： Salim S,Hayek ^[1] ; Robert,Neuman ^[1] ; Nino,Kavtaradze ^[1] ; Salman,Sher ^[1] ; Dean,Jones ^[2] ; Qunna,Li ^[1] ; Liping,Zhao ^[3] ; Suephy C,Chen ^[4] ; Edmund,Waller ^[5] ; Arshed,Quyyumi ^[6]

作者单位： Division of Cardiology, Emory University School of Medicine, Atlanta, GA, United States. ^[1] Division of Pulmonary Medicine, Emory University School of Medicine, Atlanta, GA, United States. ^[2] Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, United States. ^[3] Department of Dermatology, Atlanta VA Medical Center and Emory University School of Medicine, Atlanta, GA, United States. ^[4] Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, United States. ^[5] Division of Cardiology, Emory University School of Medicine, Atlanta, GA, United States. Electronic address: aquyyum@emory.edu. ^[6]

关键词 Arterial stiffness Endothelial progenitor cells Etanercept Flow-mediated dilation Psoriasis TNF-alpha